Alphabet Gains on New AI Model; Zealand Pharma Drops Despite Positive Trial Data

Alphabet (NASDAQ: GOOGL) shares rose in premarket trading Thursday after its Google unit announced a new artificial intelligence model, while Zealand Pharma saw its stock decline despite positive clinical trial data for an obesity treatment.

Tech Sector Rises on AI, Cloud Deals

Alphabet shares gained approximately 2% after Google unveiled Gemini 4 Argon, its latest AI model. The company stated the model offers superior performance in coding and cybersecurity compared to rival offerings and at a lower cost. Access will be rolled out first to cybersecurity researchers, followed by paid API customers and subscribers before a broader public release.

Other technology companies also saw premarket gains on significant business agreements:

• Oracle (NYSE: ORCL) rose 1.6% following a Financial Times report that Tencent signed a $7 billion, five-year deal to access Oracle's advanced AI chips through its data centers in Southeast Asia.
• Synopsys (NASDAQ: SNPS) gained 2.5% after announcing a multiyear agreement with Amazon Web Services valued at over $1 billion. AWS will license Synopsys' chip design software and intellectual property for its custom processors.

Healthcare Stocks See Divergent Moves

Ad

Zealand Pharma (NASDAQ: ZELA) shares fell 11.7% in premarket action. The decline came after its partner, Boehringer Ingelheim, announced that their dual glucagon/GLP-1 agonist, survodutide, met its primary endpoints in a Phase 3 trial for weight management. The study showed patients achieved up to a 13.1% average body-weight reduction over 76 weeks, compared to 3.1% for placebo.

In contrast, Monte Rosa Therapeutics (NASDAQ: GLUE) surged 20% ahead of its planned presentation of complete Phase 1 clinical results for its molecular glue degrader, MRT-8102. Meanwhile, Liquidia (NASDAQ: LQDA) shares dropped 5.2% after a Delaware federal court ruled that its inhaled therapy, YUTREPIA, infringed on a patent held by United Therapeutics.

Other Notable Movers

Among other companies making significant premarket moves, Rocket Lab (NASDAQ: RKLB) shares climbed 5.2%. The space company announced the largest single commercial launch agreement in its history, a 20-mission contract with Tokyo-based Synspective.

Vicor (NASDAQ: VICR) jumped 10.8% after the power component manufacturer raised its third-quarter sequential revenue growth forecast to more than 30% from a prior outlook of more than 20%, citing higher-than-expected technology licensing royalties.